Fig. 1

Loureirin B inhibits the proliferation of HSCs. a Activated hepatic stellate cells (aHSCs) were treated with 12.5, 25, 50, 100, 200 or 400 ng/μl loureirin B for 48 h, and then detected using the MTT assay. b aHSCs were treated with 100 ng/μl loureirin B for 24, 48 and 72 h, and then detected using the MTT assay. The experiments were repeated three times. *p < 0.05; **p < 0.01; ***p < 0.001